Breakthrough blood test could spare unborn babies from painful needle tests
NCT ID NCT03622892
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new way to diagnose cystic fibrosis in unborn babies using a simple blood sample from the mother. Instead of using a needle to take fluid from around the baby, researchers used advanced DNA sequencing to read the baby's genes from tiny bits of fetal DNA floating in the mother's blood. The study included 28 families who already knew their baby was at risk for cystic fibrosis. If this method proves reliable, it could make prenatal testing safer and less stressful for families.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a safer, noninvasive way to diagnose cystic fibrosis in unborn babies, replacing risky invasive tests.
What could go wrong
This was a small, early-stage study with only 28 participants. The method may not be accurate enough for routine use and needs much larger validation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CH Saint Brieuc
Saint-Brieuc, 22000, France
-
CHRU de Brest
Brest, 29609, France
-
CHRU de Dijon
Dijon, 21079, France
-
CHU de Nantes
Nantes, 44093, France
-
CHU de Rennes
Rennes, 35000, France
-
CHU de Rouen
Rouen, 76031, France